Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Intra-Cellular Therapies (ITCI)
NASDAQ:ITCI
RESEARCH TOOLSreports
Intra-Cellular Therapies (ITCI) Ownership Overview
1.27% Insiders
32.16% Mutual Funds
27.86% Other Institutional Investors
13.30% ETFs
25.41% Public Companies and Individual Investors
The ownership structure of Intra-Cellular Therapies (ITCI) stock is a mix of institutional, retail, and individual investors. Approximately 73.32% of the company’s stock is owned by Institutional Investors, 1.27% is owned by Insiders, and 25.41% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 20, 2024 | Mark Neumann Evp & Cco | xxxxxxxxxxxxx | $1405047 |
| Jun 25, 2024 | Rory Riggs Ceo,director, >10% Owner | xxxxxxxxxxxxx | $337193 |
| Feb 28, 2024 | Robert Van Nostrand Director | xxxxxxxxxxxxx | $1458650 |
| Feb 27, 2024 | Joel Marcus Director | xxxxxxxxxxxxx | $1808253 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $250977 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $267264 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $919304 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $3340800 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,148,814 | Institution | 8.61% | 1,169,401,405 | |
| 8,587,446 | Institution | 8.08% | 1,097,647,348 | |
| 4,426,740 | Institution | 4.17% | 565,825,907 | |
| 2,864,689 | Institution | 2.70% | 366,164,548 | |
| 2,067,410 | Institution | 1.95% | 264,256,346 | |
| 1,891,074 | Institution | 1.78% | 241,717,079 | |
| 1,693,407 | Institution | 1.59% | 216,451,283 | |
| 1,622,215 | Institution | 1.53% | 207,351,521 | |
| 1,202,491 | Institution | 1.13% | 153,702,400 | |
| 1,137,103 | Institution | 1.07% | 145,344,505 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,587,446 | Institution | 8.08% | 1,097,647,348 | |
| 4,426,740 | Institution | 4.17% | 565,825,907 | |
| 2,067,410 | Institution | 1.95% | 264,256,346 | |
| 1,891,074 | Institution | 1.78% | 241,717,079 | |
| 1,693,407 | Institution | 1.59% | 216,451,283 | |
| 1,202,491 | Institution | 1.13% | 153,702,400 | |
| 1,137,103 | Institution | 1.07% | 145,344,505 | |
| 984,856 | Institution | 0.93% | 125,884,294 | |
| 773,424 | Institution | 0.73% | 98,859,056 | |
| 741,676 | Institution | 0.70% | 94,801,026 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,168,294 | Institution | 2.98% | 264,615,915 | |
| 2,564,700 | Institution | 2.41% | 214,203,744 | |
| 1,491,406 | Institution | 1.40% | 124,562,229 | |
| 1,452,674 | Institution | 1.37% | 121,327,332 | |
| 619,916 | Institution | 0.58% | 79,237,663 | |
| 595,430 | Institution | 0.56% | 76,107,863 | |
| 474,106 | Institution | 0.45% | 60,714,014 | |
| 403,894 | Institution | 0.38% | 51,625,731 | |
| 365,714 | Institution | 0.34% | 46,745,563 | |
| 336,849 | Institution | 0.32% | 43,056,039 |
FAQ
Who Owns Intra-Cellular Therapies (ITCI)?
According to the latest TipRanks data, approximately 27.86% of the company's stock is held by institutional investors, 1.27% is held by insiders, and 25.41% is held by retail investors.
What percentage of Intra-Cellular Therapies (ITCI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 27.86% of Intra-Cellular Therapies (ITCI) stock is held by institutional investors.
What percentage of Intra-Cellular Therapies (ITCI) stock is held by retail investors?
According to the latest TipRanks data, approximately 25.41% of Intra-Cellular Therapies (ITCI) stock is held by retail investors.
Who owns the most shares of Intra-Cellular Therapies (ITCI)?
Vanguard owns the most shares of Intra-Cellular Therapies (ITCI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.